MRI may predict adverse tissue reaction in metal-on-metal hip replacement patients

Magnetic Resonance Imaging (MRI) can detect a failing, or potentially failing, metal-on-metal hip implant (MoM) early on, according to a new study presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). Early detection can result in timely revision surgery, decreasing the risk for further tissue damage and pain.

Researchers reviewed the of 70 patients who ultimately underwent revision surgery for a failed MoM implant. The images were assessed for the presence of tissue damage, swelling and other characteristics.

The study found that an MRI is highly sensitive and specific to identifying tissue damage in MoM total hip replacement (THR) patients. Early identification of at- can result in timely revision surgery, when necessary, decreasing pain and future damage to surrounding hip tissue.

Also today at the 2013 AAOS Annual meeting, the educational session "Optimizing Management of Patients with Metal-on-metal Hips," featured seven orthopaedic experts discussing the identification and treatment of MoM hip failure.

In December 2012, the Academy issued an Information Statement on Metal-on-metal Hip Arthroplasty (replacement) recommending a "low threshold" for commencing the evaluation of a patient with an MoM hip replacement, as "early recognition and diagnosis will facilitate the initiation of appropriate treatment prior to significant adverse biological reactions." The statement also provides a detailed overview of various diagnostic and treatment methods to limit patient discomfort, and outlines when to quickly initiate treatment, and if necessary revision.

Related Stories

You have your MoM's ions

date Mar 09, 2010

Hip replacement patients with metal-on-metal (MoM) implants (both the socket and hip ball are metal) pass metal ions to their infants during pregnancy, according to a new study presented today at the 2010 Annual Meeting of ...

Recommended for you

Drug and device firms paid $6.5B to care providers

date Jun 30, 2015

From research dollars to free lunches and junkets, drug and medical device companies paid doctors and leading hospitals nearly $6.5 billion last year, according to government data posted Tuesday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.